Inventiva S.A. Sponsored ADR (IVA) vs Pharming Group N.V. Sponsored ADR (PHAR)

Inventiva S.A. Sponsored ADR and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. Inventiva S.A. Sponsored ADR and Pharming Group N.V. Sponsored ADR are of similar size ($870.6M and $867.9M). Inventiva S.A. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 34.2×. Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against 6.76%. Pharming Group N.V. Sponsored ADR has the higher net margin (6.27% vs −750.3%) and the higher return on invested capital (10.1% vs 0.00%). Across the 19 metrics below, Pharming Group N.V. Sponsored ADR leads on 14 and Inventiva S.A. Sponsored ADR on 5.

Valuation

Metric IVA PHAR Biotechnology median
P/E n/m 34.22 10.60
P/S 7.43 2.23 9.40
P/B 2.13 2.96 2.13
Price to free cash flow n/m 25.00 25.18
EV/EBITDA n/m 17.39 0.66
EV/Sales 1.54 2.00 9.02
Earnings yield (94.51%) 2.92% (32.88%)
Free cash flow yield (94.32%) 4.00% (23.13%)

Profitability

Metric IVA PHAR Biotechnology median
Gross margin 0.00% 85.10% 68.51%
Operating margin 0.00% 8.40% 0.00%
Net margin (750.28%) 6.27% 0.00%
Free cash flow margin 0.00% 8.92% 0.00%
Return on equity 0.00% 8.73% (51.96%)
Return on assets 0.00% 5.00% (46.06%)
Return on invested capital 0.00% 10.07% 0.00%

Growth

Metric IVA PHAR Biotechnology median
Revenue growth (TTM) 547.89% 6.76% 6.76%
EPS growth (last fiscal year) 35.44% 125.00% 29.88%
Revenue growth, 5-year CAGR 8.33% 12.13% 9.75%
Net income growth, 5-year CAGR 0.00% (40.35%) 0.00%

Health

Metric IVA PHAR Biotechnology median
Debt to equity 1.13 0.34 0.00
Current ratio 3.81 3.23 4.97
Net debt to EBITDA 0.29 (2.21) 1.01

Dividend

Metric IVA PHAR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IVA PHAR Biotechnology median
Market cap 867.93m 870.59m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack